Evidence map›Paper›PMID 15326479›Full record

ArticleOncogene2004

Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance.

Charles Dudognon, Frédéric Pendino, Josette Hillion, Anne Saumet, Michel Lanotte, Evelyne Ségal-Bendirdjian

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Review
  3. Biomedicines · 2022
    Article
  4. Article
  5. Frontiers in oncology · 2021
    Article
  6. Non-canonical Roles of Telomerase: Unraveling the Imbroglio.Frontiers in cell and developmental biology · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Separation of telomerase functions by reverse genetics.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  19. Human telomerase model shows the role of the TEN domain in advancing the double helix for the next polymerization step.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Charles DudognonINSERM U496, Institut d'Hématologie, Hôpital Saint-Louis, 1, Avenue Claude Vellefaux, 75010 Paris, France.
Frédéric Pendino
Josette Hillion
Anne Saumet
Michel Lanotte
Evelyne Ségal-Bendirdjian
Inserm · FRHôpital Saint-Louis · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human telomerase has been implicated in cell immortalization and cancer. Recent works suggest that telomerase confers additional function required for tumorigenesis that does not depend on its ability to maintain telomeres. This new action may influence tumor therapy outcomes by yet unraveled mechanisms. Here, we show that overexpression of the catalytic subunit of telomerase (hTERT) protects a maturation-resistant acute promyelocytic leukemia (APL) cell line from apoptosis induced by the tumor necrosis factor (TNF) or TNF-related apoptosis-inducing ligand (TRAIL) and not from apoptosis induced by chemotherapeutic drugs such as etoposide or cisplatin. Conversely, in these cells, TRAIL-induced cell death is magnified by all-trans retinoic acid (ATRA) treatment, independently of telomerase activity on telomeres. Of note, this response is subordinated neither to maturation nor to telomere shortening. This work underlines that retinoids and death receptor signaling cross-talks offer new perspectives for antitumor therapy.

Indexed as

Signal TransductionTelomereApoptosisApoptosis Regulatory ProteinsDNA-Binding ProteinsGreen Fluorescent ProteinsHumansLuminescent ProteinsMembrane GlycoproteinsReceptors, Tumor Necrosis FactorTelomeraseTNF-Related Apoptosis-Inducing LigandTretinoinTumor Necrosis Factor-alphaApoptosis Regulatory ProteinsDNA-Binding ProteinsGreen Fluorescent ProteinsLuminescent ProteinsMembrane GlycoproteinsReceptors, Tumor Necrosis FactorTelomeraseTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanTretinoinTumor Necrosis Factor-alpha

Identifiers

PMID15326479
OpenAlexW1978006437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.